White House warns over lackluster FDA funding increase in incoming appropriations bill
The White House said Wednesday that it “strongly supports” a Senate appropriations bill that’s making its way through Congress this week and would include the FDA’s funds for the next fiscal year.
But the Biden administration also said Wednesday morning that at the funding level specified for FDA, the agency would need to do some serious juggling of its books to maintain its current staff levels.
Biden’s team notes an increase of only about $20 million for the FDA through the end of September 2024, as per the Senate bill text, adding:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.